Personalized Immune Cell Treatment NKCL Classic
NKCL母公司GK国际集团项目推介活动于8月30日在马来西亚吉隆坡举行。本活动由马来西亚国家新闻社BERNAMA为代表,中国时报等中华圈媒体参加并进行报道 当天介绍的GK国际集团的项目有NKCL(利用免疫细胞治疗剂的免疫护理平台)。 除此之外,与以马来西亚，中国，中国香港,新加坡为中心的中华圈市场中,共同开展商务活动的合作伙伴 IN...
Even if 2 to 4 billion NK cells are injected, only 10 to 20% reach cancer cells on average. The reason is that, before reaching the cancer cells, it is dispersed into bad blood and other diseases in the blood, and it has a therapeutic effect. NKCL has developed technology to reach up to 70% or more o...
